Pain catastrophizing is associated with the Val66Met polymorphism of the brain-derived neurotrophic factor in fibromyalgia

被引:16
|
作者
da Silveira Alves, Camila Fernanda [1 ,2 ,3 ,4 ]
Caumo, Wolnei [3 ,4 ,5 ]
Silvestri, Joana Morez [2 ]
Zortea, Maxciel [3 ,4 ]
dos Santos, Vinicius Souza [3 ,4 ]
Cardoso, Dayane Favarin [2 ]
Regner, Andrea [1 ]
de Souza, Alessandra Hubner [1 ]
Simon, Daniel [1 ,2 ]
机构
[1] Univ Luterana Brasil ULBRA, Grad Program Cellular & Mol Biol Appl Hlth, Av Farroupilha,8001 Predio 22,5 Andar, BR-92425900 Canoas, RS, Brazil
[2] Univ Luterana Brasil ULBRA, Human Mol Genet Lab, Canoas, Brazil
[3] Hosp Clin Porto Alegre HCPA, Lab Pain & Neuromodulat, Porto Alegre, RS, Brazil
[4] Univ Fed Rio Grande do Sul UFRGS, Grad Program Med Sci, Porto Alegre, RS, Brazil
[5] Univ Fed Rio Grande do Sul UFRGS, Hosp Clin Porto Alegre HCPA, Sch Med, Pain & Palliat Care Serv,Dept Surg, Porto Alegre, RS, Brazil
关键词
Fibromyalgia; Pain catastrophizing; BDNF; Single nucleotide polymorphism; Val66Met; BRAZILIAN PORTUGUESE VERSION; BIPOLAR DISORDER; HUMAN-MEMORY; LIFE STRESS; FACTOR GENE; BDNF; SENSITIZATION; DEPRESSION; RESPONSES; RISK;
D O I
10.1186/s42358-020-00141-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Fibromyalgia (FM) is a musculoskeletal chronic pain syndrome that impacts negatively patient's daily lives. Its pathogenesis is characterized by a complex relationship between biological and psychosocial factors not fully understood yet. Pain catastrophizing is associated with FM and is an important predictor of outcomes. This study aimed to answer two questions: (i) whether the allele and genotype frequencies of BDNF Val66Met (rs6265) polymorphism differs between FM patients and healthy controls (HC); and (ii) if the BDNF Val66Met polymorphism is a factor that predicts pain catastrophizing in FM. Methods In a cross-sectional design, 108 FM patients and 108 HC were included. FM patients responded to the Brazilian Portuguese version of the Pain Catastrophizing Scale (BP-PCS) to assess pain catastrophizing, as well as other validated tools for anxiety (The State-Trait Anxiety Inventory - STAI), depression (Beck Depression Inventory II-BDI-II) and functional aspects (Fibromyalgia Impact Questionnaire - FIQ; Central Sensitization Inventory validated and adapted for Brazilian population - CSI-BP; Pittsburgh Sleep Quality Index - PSQI; and Resilience Scale). All subjects were genotyped for the BDNF Val66Met polymorphism. Results Val allele was significantly more frequent in FM patients compared to the control group (p < 0.05). Also, FM patients with Val/Val genotype showed more pain catastrophizing thoughts, and this genotype was significantly associated with magnification and rumination dimensions of BP-PCS (p < 0.05). Furthermore, there were significant differences in levels of anxiety and symptoms of depression, years of education, and the functional situation between the FM and control groups. Conclusions The findings show an association of BDNF Val66Met polymorphism with pain catastrophizing in FM, which opens new avenues to comprehend the interplay between molecular genetic characteristics and neuroplasticity mechanisms underpinning FM.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients
    Sarchiapone, Marco
    Carli, Vladimir
    Roy, Alec
    Iacoviello, Licia
    Cuomo, Chiara
    Latella, Maria Carmela
    di Giannantonio, Massimo
    Janiri, Luigi
    de Gaetano, Monica
    Janal, Malvin N.
    NEUROPSYCHOBIOLOGY, 2008, 57 (03) : 139 - 145
  • [42] The brain-derived neurotrophic factor Val66Met polymorphism and rate of decline in Alzheimer's disease
    Chuu, Jenny Y-J
    Taylor, Joy L.
    Tinklenberg, Jared
    Noda, An
    Yesavage, Jerome
    Murphy, Greer M., Jr.
    JOURNAL OF ALZHEIMERS DISEASE, 2006, 9 (01) : 43 - 49
  • [43] Brain-derived neurotrophic factor val66met polymorphism and hippocampal volume in healthy volunteers and schizophrenia
    Szeszko, PR
    Lipsky, RH
    Mentschel, C
    Robinson, D
    Ashtari, M
    Bilder, RM
    Kane, JM
    Malhotra, AK
    BIOLOGICAL PSYCHIATRY, 2004, 55 : 200S - 200S
  • [44] Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis
    Smith, Geoffrey N.
    Thornton, Allen E.
    Lang, Donna J.
    MacEwan, G. William
    Ehmann, Thomas S.
    Kopala, Lili C.
    Tee, Karen
    Shiau, Gillian
    Voineskos, Aristotle N.
    Kennedy, James L.
    Honer, William G.
    SCHIZOPHRENIA RESEARCH, 2012, 134 (2-3) : 253 - 259
  • [45] Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Antidepressant Efficacy of Ketamine in Depressed Patients
    Laje, Gonzalo
    Lally, Niall
    Mathews, Daniel
    Brutsche, Nancy
    Chemerinski, Anat
    Akula, Nirmala
    Kelmendi, Benjamin
    Simen, Arthur
    McMahon, Francis J.
    Sanacora, Gerard
    Zarate, Carlos, Jr.
    BIOLOGICAL PSYCHIATRY, 2012, 72 (11) : E27 - E28
  • [46] Association study between the brain-derived neurotrophic factor gene polymorphism (Val66Met) and schizophrenia
    Yui, Naoe
    Shinkai, Takahiro
    Hori, Hiroko
    Ohmori, Osamu
    Matsumoto, Chima
    Nakamura, Jun
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (04) : A32 - A33
  • [47] Hippocampal Volumes and the Brain-Derived Neurotrophic Factor val66met Polymorphism in Geriatric Major Depression
    Kanellopoulos, Dora
    Gunning, Faith M.
    Morimoto, Sarah S.
    Hoptman, Matthew J.
    Murphy, Christopher F.
    Kelly, Robert E., Jr.
    Glatt, Charles
    Lim, Kelvin O.
    Alexopoulos, George S.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2011, 19 (01): : 13 - 22
  • [48] The Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Prediction of Neural Risk for Alzheimer Disease
    Voineskos, Aristotle N.
    Lerch, Jason P.
    Felsky, Daniel
    Shaikh, Sajid
    Rajji, Tarek K.
    Miranda, Dielle
    Lobaugh, Nancy J.
    Mulsant, Benoit H.
    Pollock, Bruce G.
    Kennedy, James L.
    ARCHIVES OF GENERAL PSYCHIATRY, 2011, 68 (02) : 198 - 206
  • [49] Association study of a brain-derived neurotrophic factor (Val66Met) genetic polymorphism and panic disorder
    Lam, P
    Cheng, CY
    Hong, CJ
    Tsai, SJ
    NEUROPSYCHOBIOLOGY, 2004, 49 (04) : 178 - 181
  • [50] Brain-derived neurotrophic factor Val66Met polymorphism and cognitive function in persons with cardiovascular disease
    Szabo, Ashley J.
    Alosco, Michael L.
    Miller, Lindsay A.
    Mcgeary, John E.
    Poppas, Athena
    Cohen, Ronald A.
    Gunstad, John
    PSYCHOGERIATRICS, 2013, 13 (04) : 206 - 212